e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Occupational respiratory diseases: asthma, silicosis and asbestosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study
G. Paolocci, V. Nicolic, I. Folletti, K. Torén, A. Gambelunghe, M. dell'Omo, G. Muzi, G. Abbritti, N. Murgia (Perugia, Italy; Göteborg, Sweden)
Source:
Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Session:
Occupational respiratory diseases: asthma, silicosis and asbestosis
Session type:
Poster Discussion
Number:
1912
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Paolocci, V. Nicolic, I. Folletti, K. Torén, A. Gambelunghe, M. dell'Omo, G. Muzi, G. Abbritti, N. Murgia (Perugia, Italy; Göteborg, Sweden). Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study. Eur Respir J 2013; 42: Suppl. 57, 1912
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014
Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Epidemiological analysis of the incidence and risk factors for coal-workers’ pneumoconioses in the Silesia, Poland during period 2003-2011
Source: Annual Congress 2013 –Occupational respiratory diseases: obstructive, interstitial lung diseases and methods of diagnosis
Year: 2013
Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort
Source: International Congress 2016 – The best is yet to come in terms of lung function
Year: 2016
Prevalence of occupational and environmental exposures in Australian patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Occupational asthma, abestosis and silicosis
Year: 2014
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016
Diet and related lifestyle, lung function and chronic obstructive pulmonary disease in Middle Eastern and African countries: A systematic review
Source: International Congress 2014 – Chronic and acute environmental exposure effect during childhood and in the elderly
Year: 2014
Epidemiology of interstitial lung diseases. The RENIA study
Source: Eur Respir J 2001; 18: Suppl. 33, 440s
Year: 2001
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Mortality due to IPF and mesothelioma in Europe – A link with historic asbestos use?
Source: International Congress 2016 – Population-based insights into occupational and environmental lung disease
Year: 2016
Sarcoidosis in the UK: Insights from the BTS interstitial lung disease registry
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Does the
BTNL2
genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept